Abivax S.A.
ABVXAs of the close on Sep 25, 2026
Price
$91.06
Market cap
—
Figures are per ordinary share in the filer's currency; the US price is per depositary share
P/E (diluted TTM)
—
Figures are per ordinary share in the filer's currency; the US price is per depositary share
EPS (TTM)
—
Figures are per ordinary share in the filer's currency; the US price is per depositary share
Dividend yield
—
Figures are per ordinary share in the filer's currency; the US price is per depositary share
Figures shown here come from public SEC filings. Dates beside each section show the available history.
How Abivax S.A. Makes Money
No flow chart is shown because the available revenue and expense lines do not reconcile exactly. The reported financial history below remains available.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 5 annual periods. The latest annual period ends Dec 31, 2025.
Ownership
Ownership filing history is not available for this company.